U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.1346_1362del (p.Ala449fs) AND Monogenic diabetes

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 24, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003313356.1

Allele description [Variation Report for NM_000162.5(GCK):c.1346_1362del (p.Ala449fs)]

NM_000162.5(GCK):c.1346_1362del (p.Ala449fs)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.1346_1362del (p.Ala449fs)
Other names:
NM_001354803.2:c.380_396del
HGVS:
  • NC_000007.14:g.44145176_44145192del
  • NG_008847.2:g.57983_57999del
  • NM_000162.5:c.1346_1362delMANE SELECT
  • NM_001354800.1:c.1346_1362del
  • NM_001354801.1:c.335_351del
  • NM_001354802.1:c.206_222del
  • NM_001354803.2:c.380_396del
  • NM_033507.3:c.1349_1365del
  • NM_033508.3:c.1343_1359del
  • NP_000153.1:p.Ala449fs
  • NP_001341729.1:p.Ala449fs
  • NP_001341730.1:p.Ala112fs
  • NP_001341731.1:p.Ala69fs
  • NP_001341732.1:p.Ala127fs
  • NP_277042.1:p.Ala450fs
  • NP_277043.1:p.Ala448fs
  • LRG_1074t1:c.1346_1362del
  • LRG_1074t2:c.1349_1365del
  • LRG_1074:g.57983_57999del
  • LRG_1074p1:p.Ala449fs
  • LRG_1074p2:p.Ala450fs
  • NC_000007.13:g.44184775_44184791del
Protein change:
A112fs
Molecular consequence:
  • NM_000162.5:c.1346_1362del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354800.1:c.1346_1362del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354801.1:c.335_351del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354802.1:c.206_222del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001354803.2:c.380_396del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033507.3:c.1349_1365del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_033508.3:c.1343_1359del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004012128ClinGen Monogenic Diabetes Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Diabetes ACMG Specifications GCK V1.2.0)
Pathogenic
(Jun 24, 2023)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Monogenic Diabetes Variant Curation Expert Panel, SCV004012128.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.1346_1362del variant in the glucokinase gene, GCK, causes a frameshift in the protein at codon 449 (NM_000162.5), adding 4 novel amino acids before encountering a stop codon (p.(Ala449GlyfsTer4)). While this variant, located in exon 10 of 10, is predicted to cause a premature stop codon and to escape nonsense mediated decay, it is in a functionally important region of a gene where loss-of-function is an established disease mechanism (PVS1; PMID: 19790256). This variant is absent in gnomAD (PM2_Supporting). This variant was identified in 5 unrelated individuals with a clinical picture consistent with non-autoimmune/insulin-deficient diabetes (PS4_Moderate; internal lab contributors). This variant was identified in at least two individuals with a clinical history highly specific for GCK-MODY (FBG 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4_Moderate, internal lab contributors). This variant segregated with disease with 2 informative meioses in 2 families with MODY (PP1; internal lab contributors). In summary, the c.1346_1362del variant meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.2.0, approved 6/7/2023): PVS1, PP4, PS4_Moderate, PP1, PM2_Supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 22, 2023